Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F P Brunner

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Clinical Nephrology|September 1, 1992
Risks and benefits of graft biopsy in renal transplantation under cyclosporin-AD Kiss, J Landmann, M Mihatsch, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1972
Combined report on regular dialysis and transplantation in Europe, II, 1971F P Brunner, H J Gurland, H Härlen, et al.
Experientia|February 15, 1988
The angiotensin converting enzyme inhibitor enalapril in acute ischemic renal failure in ratsA M Koelz, S Bertschin, M Hermle, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 29, 1998
Evidence for disturbed S-adenosylmethionine : S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions?F M Loehrer, C P Angst, F P Brunner, et al.
Acta Paediatrica Scandinavica|March 1, 1976
Dialysis and renal transplantation of children in Europe, 1973K Schärer, F M Parsons, F P Brunner, et al.
Schweizerische Medizinische Wochenschrift|October 16, 1982
[Phenacetin abuse. VII: Urinary tract tumors in dialysis patients and patients with kidney grafts]M J Mihatsch, F P Brunner, E Korteweg, et al.
Contributions to Nephrology|January 1, 1986
Low-dose ciclosporin in cadaveric renal transplantationG Thiel, M J Mihatsch, R Martin, et al.
Schweizerische Medizinische Wochenschrift|January 28, 1980
[Phenacetin abuse I. Occurrence, per capita consumption and costs of treatment]M J Mihatsch, H O Hofer, F Gutzwiler, et al.
Transplantation Proceedings|October 1, 1984
Graft survival and policies regarding blood transfusion and cold ischemia time in renal transplantation in EuropeH Brynger, F P Brunner, C Jacobs, et al.
Transplantation Proceedings|October 1, 1994
Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 yearsG Thiel, A Bock, M Spöndlin, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Clinical Nephrology|September 1, 1992
Risks and benefits of graft biopsy in renal transplantation under cyclosporin-AD Kiss, J Landmann, M Mihatsch, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1972
Combined report on regular dialysis and transplantation in Europe, II, 1971F P Brunner, H J Gurland, H Härlen, et al.
Experientia|February 15, 1988
The angiotensin converting enzyme inhibitor enalapril in acute ischemic renal failure in ratsA M Koelz, S Bertschin, M Hermle, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 29, 1998
Evidence for disturbed S-adenosylmethionine : S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions?F M Loehrer, C P Angst, F P Brunner, et al.
Acta Paediatrica Scandinavica|March 1, 1976
Dialysis and renal transplantation of children in Europe, 1973K Schärer, F M Parsons, F P Brunner, et al.
Schweizerische Medizinische Wochenschrift|October 16, 1982
[Phenacetin abuse. VII: Urinary tract tumors in dialysis patients and patients with kidney grafts]M J Mihatsch, F P Brunner, E Korteweg, et al.
Contributions to Nephrology|January 1, 1986
Low-dose ciclosporin in cadaveric renal transplantationG Thiel, M J Mihatsch, R Martin, et al.
Schweizerische Medizinische Wochenschrift|January 28, 1980
[Phenacetin abuse I. Occurrence, per capita consumption and costs of treatment]M J Mihatsch, H O Hofer, F Gutzwiler, et al.
Transplantation Proceedings|October 1, 1984
Graft survival and policies regarding blood transfusion and cold ischemia time in renal transplantation in EuropeH Brynger, F P Brunner, C Jacobs, et al.
Transplantation Proceedings|October 1, 1994
Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 yearsG Thiel, A Bock, M Spöndlin, et al.
Pageof 13